DEFICIENT BIM EXPRESSION AS A MECHANISM OF INTRINSIC AND ACQUIRED RESISTANCE TO TARGETED THERAPIES IN EGFR-MUTANT AND ALK-POSITIVE LUNG CANCERS

The General Hospital Corporation

Investigators